vs
FARMERS NATIONAL BANC CORP（FMNB）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是FARMERS NATIONAL BANC CORP的1.1倍（$75.5M vs $71.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 3.2%），FARMERS NATIONAL BANC CORP自由现金流更多（$52.2M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 6.2%）
Farmers National Banc Corp（俄亥俄州）是总部位于美国俄亥俄州的地区性金融控股公司，提供零售及商业银行、财富管理、保险等多元服务，主要服务俄亥俄州及美国中西部邻近区域的个人、中小企业与本地社区客户。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
FMNB vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.1倍
$71.5M
营收增速更快
PBYI
高出24.6%
3.2%
自由现金流更多
FMNB
多$37.8M
$14.4M
两年增速更快
PBYI
近两年复合增速
6.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $71.5M | $75.5M |
| 净利润 | $14.6M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 24.8% | 22.7% |
| 净利率 | 20.5% | — |
| 营收同比 | 3.2% | 27.7% |
| 净利润同比 | 1.7% | — |
| 每股收益（稀释后） | $0.39 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FMNBPBYI
| Q4 25 | $71.5M | $75.5M | ||
| Q3 25 | $70.8M | $54.5M | ||
| Q2 25 | $69.8M | $52.4M | ||
| Q1 25 | $67.8M | $46.0M | ||
| Q4 24 | $69.3M | $59.1M | ||
| Q3 24 | $70.3M | $80.5M | ||
| Q2 24 | $66.5M | $47.1M | ||
| Q1 24 | $63.4M | $43.8M |
净利润FMNBPBYI
| Q4 25 | $14.6M | — | ||
| Q3 25 | $12.5M | $8.8M | ||
| Q2 25 | $13.9M | $5.9M | ||
| Q1 25 | $13.6M | $3.0M | ||
| Q4 24 | $14.4M | — | ||
| Q3 24 | $8.5M | $20.3M | ||
| Q2 24 | $11.8M | $-4.5M | ||
| Q1 24 | $11.2M | $-4.8M |
毛利率FMNBPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率FMNBPBYI
| Q4 25 | 24.8% | 22.7% | ||
| Q3 25 | 20.7% | 17.6% | ||
| Q2 25 | 23.4% | 12.7% | ||
| Q1 25 | 24.1% | 8.7% | ||
| Q4 24 | 25.5% | 22.6% | ||
| Q3 24 | 14.4% | 27.4% | ||
| Q2 24 | 21.3% | -4.6% | ||
| Q1 24 | 21.2% | -5.3% |
净利率FMNBPBYI
| Q4 25 | 20.5% | — | ||
| Q3 25 | 17.6% | 16.2% | ||
| Q2 25 | 19.9% | 11.2% | ||
| Q1 25 | 20.0% | 6.5% | ||
| Q4 24 | 20.8% | — | ||
| Q3 24 | 12.1% | 25.2% | ||
| Q2 24 | 17.7% | -9.6% | ||
| Q1 24 | 17.7% | -11.0% |
每股收益（稀释后）FMNBPBYI
| Q4 25 | $0.39 | $0.26 | ||
| Q3 25 | $0.33 | $0.17 | ||
| Q2 25 | $0.37 | $0.12 | ||
| Q1 25 | $0.36 | $0.06 | ||
| Q4 24 | $0.38 | $0.40 | ||
| Q3 24 | $0.23 | $0.41 | ||
| Q2 24 | $0.31 | $-0.09 | ||
| Q1 24 | $0.30 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | $86.7M | $22.7M |
| 股东权益账面价值 | $485.7M | $130.3M |
| 总资产 | $5.2B | $216.3M |
| 负债/权益比越低杠杆越低 | 0.18× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资FMNBPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | — | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务FMNBPBYI
| Q4 25 | $86.7M | $22.7M | ||
| Q3 25 | $86.6M | $34.0M | ||
| Q2 25 | $86.4M | $45.3M | ||
| Q1 25 | $86.3M | $56.7M | ||
| Q4 24 | $86.2M | $68.0M | ||
| Q3 24 | $86.0M | $79.3M | ||
| Q2 24 | $88.9M | $90.7M | ||
| Q1 24 | $88.8M | $102.0M |
股东权益FMNBPBYI
| Q4 25 | $485.7M | $130.3M | ||
| Q3 25 | $465.9M | $115.3M | ||
| Q2 25 | $437.7M | $104.7M | ||
| Q1 25 | $429.1M | $97.1M | ||
| Q4 24 | $406.0M | $92.1M | ||
| Q3 24 | $439.7M | $71.1M | ||
| Q2 24 | $396.7M | $48.5M | ||
| Q1 24 | $397.0M | $51.0M |
总资产FMNBPBYI
| Q4 25 | $5.2B | $216.3M | ||
| Q3 25 | $5.2B | $202.9M | ||
| Q2 25 | $5.2B | $194.9M | ||
| Q1 25 | $5.2B | $196.2M | ||
| Q4 24 | $5.1B | $213.3M | ||
| Q3 24 | $5.2B | $220.7M | ||
| Q2 24 | $5.2B | $205.0M | ||
| Q1 24 | $5.1B | $214.1M |
负债/权益比FMNBPBYI
| Q4 25 | 0.18× | 0.17× | ||
| Q3 25 | 0.19× | 0.30× | ||
| Q2 25 | 0.20× | 0.43× | ||
| Q1 25 | 0.20× | 0.58× | ||
| Q4 24 | 0.21× | 0.74× | ||
| Q3 24 | 0.20× | 1.12× | ||
| Q2 24 | 0.22× | 1.87× | ||
| Q1 24 | 0.22× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.0M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $52.2M | $14.4M |
| 自由现金流率自由现金流/营收 | 73.0% | 19.1% |
| 资本支出强度资本支出/营收 | 11.0% | 0.0% |
| 现金转化率经营现金流/净利润 | 4.10× | — |
| 过去12个月自由现金流最近4个季度 | $85.8M | $41.7M |
8季度趋势，按日历期对齐
经营现金流FMNBPBYI
| Q4 25 | $60.0M | $14.4M | ||
| Q3 25 | $10.7M | $9.7M | ||
| Q2 25 | $14.0M | $14.1M | ||
| Q1 25 | $15.7M | $3.6M | ||
| Q4 24 | $66.6M | $15.6M | ||
| Q3 24 | $23.9M | $11.0M | ||
| Q2 24 | $16.6M | $1.0M | ||
| Q1 24 | $13.7M | $11.2M |
自由现金流FMNBPBYI
| Q4 25 | $52.2M | $14.4M | ||
| Q3 25 | $9.0M | $9.7M | ||
| Q2 25 | $12.4M | $14.1M | ||
| Q1 25 | $12.2M | $3.6M | ||
| Q4 24 | $54.9M | $15.6M | ||
| Q3 24 | $20.4M | $11.0M | ||
| Q2 24 | $14.4M | $1.0M | ||
| Q1 24 | $12.2M | — |
自由现金流率FMNBPBYI
| Q4 25 | 73.0% | 19.1% | ||
| Q3 25 | 12.8% | 17.7% | ||
| Q2 25 | 17.8% | 26.8% | ||
| Q1 25 | 18.0% | 7.7% | ||
| Q4 24 | 79.2% | 26.4% | ||
| Q3 24 | 29.1% | 13.7% | ||
| Q2 24 | 21.6% | 2.1% | ||
| Q1 24 | 19.2% | — |
资本支出强度FMNBPBYI
| Q4 25 | 11.0% | 0.0% | ||
| Q3 25 | 2.4% | 0.0% | ||
| Q2 25 | 2.3% | 0.0% | ||
| Q1 25 | 5.2% | 0.1% | ||
| Q4 24 | 16.9% | 0.0% | ||
| Q3 24 | 4.9% | 0.0% | ||
| Q2 24 | 3.3% | 0.0% | ||
| Q1 24 | 2.4% | 0.0% |
现金转化率FMNBPBYI
| Q4 25 | 4.10× | — | ||
| Q3 25 | 0.86× | 1.10× | ||
| Q2 25 | 1.01× | 2.41× | ||
| Q1 25 | 1.15× | 1.21× | ||
| Q4 24 | 4.63× | — | ||
| Q3 24 | 2.80× | 0.54× | ||
| Q2 24 | 1.41× | — | ||
| Q1 24 | 1.22× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
